Several peptides containing the NGR tripeptide motif that specifically recognize the CD13 receptor isoform on tumor cells have been successfully used for the delivery of various compounds and chemotherapeutic drugs to tumor vessels [30–37]. The gene discussed is RTN4R; the disease is neoplasm.